Financhill
Sell
20

MRKR Quote, Financials, Valuation and Earnings

Last price:
$2.51
Seasonality move :
14.01%
Day range:
$2.50 - $2.71
52-week range:
$2.44 - $5.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.65x
Volume:
26.5K
Avg. volume:
78.8K
1-year change:
-47.3%
Market cap:
$27.2M
Revenue:
--
EPS (TTM):
-$1.10

Earnings Data

Next earnings date for MRKR
Mar 25
2025
Most recent earnings per share
-$0.26
Beat by $0.13
(Nov 14/2024)
Consensus Estimate
-$0.39
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRKR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $1M -- -- -$0.32 --
03/25/2025 Q4 $1M -- -- -$0.28 --
11/14/2024 Q3 $1M -- -$0.26 -$0.39 $0.13
08/14/2024 Q2 -- -- -$0.25 -$0.43 $0.18
05/15/2024 Q1 -- -- -$0.27 -$0.25 -$0.02
03/25/2024 Q4 -- -- -$0.32 -- --
11/09/2023 Q3 -- -- -$0.34 -- --
08/14/2023 Q2 -- -- $0.29 -- --
05/15/2023 Q1 -- -- -$0.57 -- --
03/22/2023 Q4 -- -- -$0.45 -- --
11/10/2022 Q3 $266.7K -- -$0.83 -$1.30 $0.47
08/11/2022 Q2 -- -- -$1.11 -- --
05/13/2022 Q1 -- -- -$1.19 -- --
03/17/2022 Q4 -- -- -$1.17 -- --
11/10/2021 Q3 -- -- -$1.50 -- --
08/10/2021 Q2 -- -- -$1.30 -- --
05/12/2021 Q1 -- -- -$1.60 -- --
03/09/2021 Q4 -- -$466.8K -$1.80 -- --
11/09/2020 Q3 -- -- -$1.60 -- --
08/10/2020 Q2 -- $466.8K -$1.40 -- --
05/11/2020 Q1 -- -- -$1.40 -- --
03/12/2020 Q4 -- $213.2K -$1.10 -- --
11/12/2019 Q3 -- -- -$1.20 -- --
07/22/2019 Q2 -- -- -$1.20 -- --
05/09/2019 Q1 -- -- -$1.20 -- --
03/15/2019 Q4 -- -- -$29.83 -- --
11/13/2018 Q3 -- -- -$3.20 -- --
08/09/2018 Q2 -- $206K -$4.10 -- --
04/05/2018 Q1 -- -- -$3.00 -- --
12/31/2017 Q4 -- -- -$2.50 -- --
11/15/2017 Q3 -- $183.1K -$3.90 -- --
08/31/2017 Q2 -- -- -$2.20 -- --
03/31/2017 Q1 -- -- -$2.90 -- --
12/31/2016 Q4 -- -- -$2.20 -- --
09/30/2016 Q3 -- -- -$2.90 -- --
06/30/2016 Q2 -- -- $3.50 -- --
03/31/2016 Q1 -- -- -$8.10 -- --
12/31/2015 Q4 -- -- $13.10 -- --
09/30/2015 Q3 -- -- $42.30 -- --
06/30/2015 Q2 -- -- -$216.00 -- --
03/31/2015 Q1 -- -- -$3.60 -- --

Marker Therapeutics Earnings Questions

  • How Much did Marker Therapeutics Generate in Revenue Last Quarter?

    Marker Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Marker Therapeutics Beat Earnings Last Quarter?

    Marker Therapeutics announced earnings per share of -$0.26 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Marker Therapeutics Profitable?

    Marker Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Marker Therapeutics EPS Next Year?

    Marker Therapeutics's earnings are forecast to decrease from -$0.94 per share to -$1.05 per share next year representing a decrease of -11.7%.

  • When is Marker Therapeutics's Earnings Date?

    Marker Therapeutics's next earnings date is March 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Target a Dividend King?
Is Target a Dividend King?

Popular retail giant Target Corporation (NYSE:TGT) has been in a…

Is COWZ ETF a Good Investment?
Is COWZ ETF a Good Investment?

There’s a reason even Warren Buffett advocates his heirs to…

3 Stocks Buffett Is Betting On
3 Stocks Buffett Is Betting On

Warren Buffett appeared to take a hard look at the…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 110x

Sell
40
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
72
HEES alert for Jan 15

H&E Equipment Services [HEES] is up 105.42% over the past day.

Sell
26
SIG alert for Jan 15

Signet Jewelers [SIG] is down 21.66% over the past day.

Sell
45
WGS alert for Jan 15

GeneDx Holdings [WGS] is down 15.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock